News

Under the collaboration agreement between Auxilium and Actelion, Actelion received exclusive rights to commercialize Xiaflex for the treatment of Dupuytren’s contracture and Peyronie’s disease in Canada, Australia, Brazil

The SL TNX-102 (2.4mg) tablet was demonstrated to provide faster delivery and efficient absorption of cyclobenzaprine as compared to the currently available pills that deliver cyclobenzaprine to the

The move follows the recall of the ingredient by Sedona Labs’ supplier of Galactooligosaccharide for a possible Salmonella contamination. Salmonella is an organism which can cause serious and

Tamibarotene is an orally available, rationally designed, synthetic retinoid compound that was designed to be more potent than the chemotherapeutic agent all-trans retinoic acid (ATRA), which selectively bind

The trial included 1,102 women with locally advanced or metastatic breast cancer previously treated with anthracyclines and taxanes either in the (neo) adjuvant setting or for locally advanced

The collaboration, which is aligned with the Russian Government initiative, is aimed at building new pharmaceutical industry and widening therapeutic opportunities for the patients in Russia. CDRI chairman

The 2011/2012 criteria support the Stage 1 meaningful use measures required to qualify eligible providers and hospitals for funding under the American Recovery and Reinvestment Act. Fujifilm medical

OnBase is expected to reduce the cost and physical space required for storing paper patient records and to provide the workflow to streamline document-based processes. Bart’s Health NHS

As part of the agreement, Janssen will pay an initial payment of $8mn and future milestone payments of $200mn to $300 mn per product along with sales royalties